UK diagnostics company Owlstone Medical was among winners of a $1 million award that will help develop new devices for patients with idiopathic pulmonary fibrosis (IPF).
Patients stand to benefit from moves to replace conventional paper-based drug product information with an electronic system compatible with smartphones and computers, a conference heard.
Sanofi is one of several pharma companies that is on a quest to use digital health to make trials cheaper and more effective – and has found another partner to help it.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.